New Products: Pathogenica's HAI BioDetection Kit; Ariosa's Harmony Prenatal Test | GenomeWeb

Pathogenica has launched its HAI BioDetection Kit to detect hospital acquired infections using its DxSeq technology platform.

The kit uses next-gen sequencing to screen for 12 different pathogens and 15 resistance gene families in a single assay. Up to 12 patient samples can be tested at once, enabling dozens of samples to be tested in one day, according to the company.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.